Skip to main content
Equibles

David M. Sellin

Analyst

Piper Sandler

Equibles does not estimate personal net worth.

About David M. Sellin

David M. Sellin is recorded as Analyst at Piper Sandler. David M. Sellin has spoken on 1 earnings call across 1 company, most recently for Alkermes plc. on November 3, 2026. The companies whose calls David M. Sellin spoke on are classified in the Healthcare sector.

David M. Sellin on recent calls

“So, regarding the launch of Takeda's oviparexin, do you perceive any potential impact to Lumerize in terms of new starts next year in NT1? So, that's And then looking longer term with the IH launch for Lumerize in 28, how are you envisioning uptake?”
Analyst — Piper Sandler, Q3 2026 Alkermes plc Earnings Conference Call ·

Affiliation history

  • Piper Sandler

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity